Global Radio-Frequency Identification (RFID) in Pharmaceuticals market cagr 11.7%

Page 1


Radio-Frequency Identification (RFID) in Pharmaceuticals Market

Radio-Frequency Identification (RFID) in Pharmaceuticals Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031

Request Sample Report

Radio-Frequency Identification (RFID) in Pharmaceuticals Market Size and Growth

The Radio-Frequency Identification (RFID) in Pharmaceuticals market is experiencing significant growth due to increasing demand for inventory management, enhanced traceability, and regulatory compliance. The market is projected to reach USD 3.2 billion by 2027, driven by technological advancements and rising awareness of anti-counterfeiting measures within the pharmaceutical sector.

Request Sample Report

Companies Covered

(Covid 19 Impact Covered)

◍ Alien Technology

◍ IBM Corporation

◍ Thinfilm Electronics

◍ Smartrac

◍ Aucxis

◍ Turck

◍ CCL Label

◍ Zebra Technologies

◍ Texas Instrument

◍ Xerox Corporation

◍ Impinj

◍ GAO RFID

◍ HID Global Corporation

The RFID in Pharmaceuticals Market features key players like Alien Technology, IBM, and Zebra Technologies, enhancing asset tracking, inventory management, and counterfeit prevention. Companies leverage RFID for improved supply chain visibility, efficiency, and compliance. Notable revenues include:

- Zebra Technologies: Approx. $4.5 billion

- Impinj: Approx. $186 million

◍ Invengo Information Technology Co., Ltd.

- Xerox: Approx. $7 billion. Request Sample Report

Market Segmentation

By Application

Drug Tracing System

Drugs Quality Management

Others

Request Sample Report

By Product

Chipped RFID

Chipless RFID

Market Growth

Request Sample Report

$ X Billion USD

Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.
Global Radio-Frequency Identification (RFID) in Pharmaceuticals market cagr 11.7% by ReportPrime - Issuu